Expression of the RB protein, allelic imbalance of the RB gene and amplification of the CDK4 gene in metaplasias, dysplasias and carcinomas in Barrett's oesophagus
M. Sarbia et al., Expression of the RB protein, allelic imbalance of the RB gene and amplification of the CDK4 gene in metaplasias, dysplasias and carcinomas in Barrett's oesophagus, ANTICANC R, 21(1A), 2001, pp. 387-392
In the present study, the role of allelic loss at the retinoblastoma gene (
RB), expression of the retinoblastoma protein (pRb) and amplification at th
e CDK4 gene in the metaplasia - dysplasia - carcinoma sequence in Barrett's
oesophagus (BO) was investigated. Samples of metaplastic specialised epith
elium (SE; n=28), low-grade dysplasia (LCD; n=21), high-grade dysplasia (HG
D; n=19) and invasive adenocarcinoma (CA; n=35) derived from 36 oesophagect
omy specimens were included. Of the cases that were informative for the RB
gene (n=27), loss of heterozygosity (LOH) was found in none of the 22 SE, i
n none of the 14 LGD, in 1 of the 12 HGD (8.3%) and in 5 of the 27 CA (18.5
%). Immunohistochemically, an enhanced expression of pRb protein in LGD, HG
D and CA as compared with SE was found in most cases. In 4 carcinoma sample
s, however; a marked reduction (3 cases) or complete absence (1 case) of pR
b protein expression was found. Two out of these 4 CA samples showed LOH in
the RB gene whilst one case was heterozygous and one case was homozygous.
In contrast to the positive controls used, CDK4 amplification was not detec
table by means of differential PCR in any of the samples under investigatio
n. The present study indicated that allelic loss of the RE gene occurs late
in the metaplasia dysplasia - carcinoma sequence in BO. Immunohistochemica
lly determined loss of pRb protein expression may indicate LOH of the RE ge
ne. CDK4 gene amplification does not seem to play a role in the development
of oesophageal adenocarcinoma.